A DIAMOND AND TITANIUM RIBBON BROOCH, BY MARGHERITA BURGENER

The very light purplish-pink titanium crossover ribbon, accented to the front and back by round brilliant-cut diamonds, mounted in...

A DIAMOND AND TITANIUM RIBBON BROOCH, BY MARGHERITA BURGENER

The very light purplish-pink titanium crossover ribbon, accented to the front and back by round brilliant-cut diamonds, mounted in titanium, diamonds weighing 0.62ct total, signed and cased Margherita Burgener, 'Ribbon #1', length 5.6cm

 

All proceeds will be donated to the European Institute of Oncology based in Milan

 

Emanuela Burgener founded Ribbon for Hope in 2017 after her personal fight and recovery from breast cancer. The inspiration of the project is the symbol of the ribbon universally understood as the fight against cancer. Estée Lauder was the first to use the pink ribbon as the emblem of the fight against cancer which, today is seen in many different colours representing many different diseases.

Ribbon for Hope is a handmade titanium and diamond brooch, as many of Margherita Burgener jewels. This piece also embodies many concepts. Firstly, the ribbon is a message of hope in the advances of research and technology for the treatment of cancer. Secondly, it is a symbol that represents a large community of people in the fight against cancer including doctors, researchers, volunteers and patients. Finally and above all else, Ribbon for Hope is an important fundraising means for pivotal research that should never stop. Therefore, all the proceeds of Ribbon for Hope sales are entirely donated to the Institute of European Oncology Foundation based in Milan.

 

The European Institute of Oncology (IEO) provides patient-centred care and guarantees patients access to innovative therapies and to early clinical trials. The SHARP research programme, a GPS in metastatic breast cancer is an achievement of the strategic interest in early clinical trials. SHARP aims to identify breakdowns (genetic mutations) and map the routes that cancer cells take to invade other organs. Clinical data and biological samples from participating patients will allow experts to examine the DNA using the latest molecular screening techniques and devise an appropriate cancer treatment plan.

 

(www.ieo.it - Doctor Curigliano)

View more View less